MedPath

Confirmation trial about clinical/preventive effects of newly developed toothpaste against periodontal disease

Not Applicable
Conditions
Healthy male/female volunteers
Registration Number
JPRN-UMIN000043228
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) At the screening test, volunteers who were determined as a patient having some dental caries (over C3 level) and/or severe periodontal disease. (2) Volunteers with medical treatment for diabetic, chronic kidney, digestive, lung or cancer diseases. (3) Volunteers having some kind of systemic disease, which has serious difficulty in participating this trial. (4) Volunteers with toothbrushing not less than four times a day, including the brushing before and after breakfast, before their normal bedtime, etc. (5) Pregnant, possibly pregnant, or lactating women, during this clinical trial. (6) Volunteers who are now under the other clinical trials with some kind of medicine/food, or willing to participate in similar tests. (7) Volunteers having their stimulating saliva with no more than 3.0 mL for 5 min. (8) Volunteers having stimulating saliva with no more than a pH of 6.2. (9) Volunteers with some kind of allergy. (10) Volunteers equipped with removable denture, and/or dental implant on the dental object. (11) Volunteers falling into the habit of smoking. (12) Volunteers who have regularly used some kind of health food. (13) Volunteers who have took in some kind of antibiotic and/or antibacterial agent, regularly or within the last month to the screening test. (14) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Gingivitis index 2. Dental plaque index 3. Depth of periodontal pocket
Secondary Outcome Measures
NameTimeMethod
1. Swelling 2. Reddening 3. Existence quantification of P. gingivalis / T. forsythia in saliva 4. Free Hb value / LDH activity in saliva 5. Overall effectiveness 6. Concentrations of volatile sulfur compounds, just like H2S and Me3SH 7. IL-1beta / IL-8 activity in saliva
© Copyright 2025. All Rights Reserved by MedPath